Patents/Assignees

ALGERNON PHARMACEUTICALS Inc.

2 patents in portfolio

US12280026utility2025
Use of Repirinast in the Prophylaxis or Treatment of Renal Fibrosis or Kidney Disease
0 cites
US11744808utility2023
Compositions and Methods for Treating Non-alcoholic Steatohepatitis
0 cites